{"schema_version":"secwatch.filing_event.v1","accession":"0001121702-24-000045","form_type":"8-K","ticker":null,"cik":"0001121702","company_name":"YIELD10 BIOSCIENCE, INC.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.356820+00:00","generated_at":"2026-06-01T22:37:07.017401+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Yield10 Q1 2024 net loss $2.5M, improves cash burn; milestone payments received","bullets":["Cash at $1.6M (up from $1.1M Dec 2023); operating cash burn $0.9M vs $2.7M YoY.","Recognized $0.3M license revenue from VISION; received $2M initial payment, additional $1M milestone in May 2024.","Net loss $2.5M ($4.77 diluted share) compared to $3.8M ($18.16) in Q1 2023; results reflect 1-for-24 reverse split.","EPA approved INTERLINE herbicide for Camelina; USDA-APHIS cleared commercial planting of HT Camelina.","Building omega-3 Camelina seed inventory for aquafeed; patent granted for carbon fixation pathway and notice of allowance for yield trait C3004."],"urls":{"canonical":"https://secwatch.observer/filing/0001121702-24-000045","json":"https://secwatch.observer/filing/0001121702-24-000045.json","markdown":"https://secwatch.observer/filing/0001121702-24-000045.md","text":"https://secwatch.observer/filing/0001121702-24-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/0001121702-24-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/yten-20240515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:37:07.017401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c0ad8634ee203cd1a3beb0cb93f9c86dbf3f3729","claim":"YIELD10 BIOSCIENCE, INC. reported financial results for the three months ended March 31, 2024.","evidence_excerpt":"On May 15, 2024, Yield10 Bioscience, Inc. issued a press release announcing the financial results for the three months ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/0001121702-24-000045-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}